The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis. Borges IT, Shea CD, Ohayon J, Jones BC, Stone RD, Ostuni J, Shiee N, McFarland H, Bielekova B, Reich DS Mult Scler Relat Disord. 2013 Apr 1; 2(2):133-140. PMID: 23580931. Abstract CommentRecommendBookmarkWatch